MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.490
-0.050 (-3.25%)
Mar 9, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 87 | 52 | 20 | 38 | - | - | |
| Market Cap Growth | 80.61% | 161.26% | -48.40% | - | - | - | |
| Enterprise Value | 77 | 43 | 14 | 24 | - | - | |
| Last Close Price | 1.54 | 1.98 | 1.17 | 3.51 | - | - | |
| PB Ratio | 2097.50 | 14.25 | 41.52 | 4.52 | - | - | |
| P/TBV Ratio | 2097.50 | 14.25 | 41.52 | 4.52 | - | - | |
| Debt / Equity Ratio | - | - | - | - | - | -0.29 | |
| Net Debt / Equity Ratio | -261.38 | -2.64 | -14.97 | -1.29 | -1.15 | 0.12 | |
| Quick Ratio | 1.10 | 2.53 | 1.48 | 3.44 | 4.95 | 0.39 | |
| Current Ratio | 1.18 | 2.65 | 1.53 | 3.61 | 4.97 | 0.44 | |
| Return on Equity (ROE) | -2691.07% | -1131.02% | -440.12% | -183.39% | -332.54% | - | |
| Return on Assets (ROA) | -148.38% | -119.61% | -128.79% | -86.60% | -80.62% | -351.45% | |
| Return on Capital Employed (ROCE) | -1396.10% | -268.10% | -767.50% | -184.80% | -84.80% | 736.40% | |
| Earnings Yield | -25.56% | -44.90% | -99.74% | -42.22% | - | - | |
| Buyback Yield / Dilution | -46.79% | -67.38% | -42.95% | -75.75% | -19.23% | -17.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.